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Abstract
The golden Syrian hamster is the model of choice or the only rodent model for studying many human diseases. However,
the lack of gene targeting tools in hamsters severely limits their use in biomedical research. Here, we report the first
successful application of the CRISPR/Cas9 system to efficiently conduct gene targeting in hamsters. We designed five
synthetic single-guide RNAs (sgRNAs)—three for targeting the coding sequences for different functional domains of the
hamster STAT2 protein, one for KCNQ1, and one for PPP1R12C—and demonstrated that the CRISPR/Cas9 system is highly
efficient in introducing site-specific mutations in hamster somatic cells. We then developed unique pronuclear (PN) and
cytoplasmic injection protocols in hamsters and produced STAT2 knockout (KO) hamsters by injecting the sgRNA/Cas9,
either in the form of plasmid or mRNA, targeting exon 4 of hamster STAT2. Among the produced hamsters, 14.3% and 88.9%
harbored germline-transmitted STAT2 mutations from plasmid and mRNA injection, respectively. Notably, 10.4% of the
animals produced from mRNA injection were biallelically targeted. This is the first success in conducting site-specific gene
targeting in hamsters and can serve as the foundation for developing other genetically engineered hamster models for
human disease.
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The golden Syrian hamster (Mesocricetus auratus; also referred
to as hamster herein) offers unique advantages over other rodent
species in modeling certain human diseases. For example,
hamsters, but not mice, develop symptoms similar to those
observed in humans following infection with hantavirus [13], ebola
virus [14], or hendra virus [15]. Among many other human
diseases, hamsters are also the preferred model for studying
human oral carcinomas [16], pancreatic cancers [17], dietinduced early atheroschlerosis [18], inflammatory myopathies
[19], Clostridium difficile infection [20], and oncolytic adenoviruses [21]. In addition to disease modeling, hamsters have also
been widely used in many other areas of biological research.
According to U.S. Department of Agriculture’s report on Animals
Used in Research, about 146,000 hamsters were used in research
in 2010 in the U.S., comprising 13% of total laboratory animal
usage (http://www.aphis.usda.gov; accessed 16 September 2013).
However, the inability to target the hamster genome has
severely hampered the use of this excellent animal model for
biomedical research. Most notably, lack of gene targeting tools has
prevented the study of gene pathways and biological processes
underlying the pathogenesis of many human diseases for which the

Introduction
The CRISPR/Cas9 (Clustered Regularly Interspaced Short
Palindromic Repeats/CRISPR associated protein 9) system is an
RNA-based adaptive immune mechanism to degrade invading
plasmids and viruses by bacteria and archaea [1]. It is a
nucleoprotein complex composed of a CRISPR coded RNA
(crRNA), a trans-activating crRNA (tracrRNA), and a single Cas9
protein. The crRNA, annealed with a tracrRNA, recognizes and
directs the Cas9 endonuclease to targeted DNAs in a sequencespecific manner causing their cleavage. It was recently shown that
a synthetic sgRNA, by fusing crRNA and tracrRNA, can guide
Cas9 endonuclease to target a DNA sequence by design, resulting
in site-specific genetic modifications [2,3]. These landmark studies
have led to a string of exciting achievements of highly efficient
gene targeting not only in mice but also in several other organisms
where homologous recombination-based gene targeting strategy
was either not available or extremely inefficient [4–12]. However,
no success has been reported in employing this system to target the
golden Syrian hamster genome.
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hamster is the only suitable rodent model. Here, we report the
successful establishment of a CRIPSR/Cas9-mediated gene
targeting strategy in the Syrian hamster and the production of
hamsters carrying germline-transmitted targeted mutations in the
STAT2 gene. With the Syrian hamster being chosen as one of the
27 high priority eutherian mammals for whole-genome sequencing
by the Genome 10K project and the recent completion of draft
assembly of its genome (http://www.genome.gov), our study
provided a timely technical breakthrough in taping the full
potential of this laboratory animal.

example, brief exposure of hamster zygotes to light [25] or altering
their intracellular pH [26] resulted in a total arrest of embryonic
development. Consequently, even though we have extensive
expertise in mouse PN injection and routinely perform such
procedures in the laboratory, we failed to achieve full-term
development from injected hamster embryos using the mouse PN
injection protocol. Therefore, we systematically tested various in
vitro handling conditions to determine which might support full
term development. We then identified the best time window postegg activation (PEA) for injection and optimized the time interval
of each round of PN injection, as well as the volume and
concentration of sgRNA/Cas9 vector to be injected into a
pronucleus. Table 2 summarizes the PN injection conditions we
developed for the hamster.

Results
Design and construction of CRISPR/Cas9 gene targeting
vector
To investigate whether the CRISPR/Cas9 system could be used
for gene targeting in golden Syrian hamsters, we designed
sgRNA/Cas9 expressing vectors targeting the hamster STAT2
(one for the N-terminal domain, referred to as sgRNA/Cas9STAT2-nd, and two for the coiled-coil domain, referred to as
sgRNA/Cas9-STAT2-cc1 and sgRNA/Cas9-STAT2–cc2, respectively), KCNQ1 and PPP1R12C genes, respectively (Figure 1A;
DNA oligos used for sgRNA/Cas9 vector construction are listed in
Table 1). We chose these genes because of their roles in viral
infection (STAT2) [22], cardiovascular function (KCNQ1) [23] or
being the most widely used genomic locus for transgene
integration (PPP1R12C) [24]. To test whether the CRISPR/
Cas9 system is effective in introducing targeted mutations in
hamster cells, we transfected each of the sgRNA/Cas9 expressing
vectors individually into baby hamster kidney (BHK) fibroblasts
followed by analyzing the potential gene targeting events by using
a PCR-restriction fragment length polymorphism (PCR-RFLP)
assay (Figure 1B). We demonstrated that all of the sgRNAs were
highly efficient in directing Cas9 to generate targeted cleavages in
the hamster genome, with targeting efficiencies being 18%–66%
by the three sgRNA/Cas9 expressing vectors for STAT2, 60% for
KCNQ1 by sgRNA/Cas9-KCNQ1, and 61% for PPP1R12C by
sgRNA/Cas9-PPP1R12C (Figure 1B). To reveal the nature of the
genetic mutations introduced by these sgRNA/Cas9 vectors, we
focused on analyzing BHK cells transfected by sgRNA/Cas9STAT2-nd, sgRNA/Cas9-KCNQ1 and sgRNA/Cas9-PPP1R12C.
We PCR amplified each of the targeting sites, subcloned the genomic
PCR products into pCR-blunt vectors, and subjected the resulting
plasmids to Sanger sequencing. Our results showed that typical
insertions/deletions (indels), caused by repairing double-strand DNA
breaks during the error-prone non-homologous end joining (NHEJ)
process, were generated in each of the targeted genomic loci
(Figure 1C). We also isolated single cell-derived BHK cell colonies
by limiting dilution cloning after transfecting the cells with the
sgRNA/Cas9-STAT2-nd vector. By screening 30 cell colonies with
the PCR-RFLP assay, we identified 16 cell colonies as targeted for
the STAT2 gene (16/30; 53.3%), with ten biallelically targeted (10/
30; 33.3%) and six monoallelically targeted (6/30; 20.0%; a
representative PCR-RFLP assay for these colonies is shown in
Figure 1D). Therefore, we demonstrated that CRISPR/Cas9 is a
highly efficient system for generating targeted mutations in the
golden Syrian hamster genome.

Production of STAT2 KO hamsters by PN injection of DNA
To investigate whether genetically targeted hamsters can be
produced by injecting the CRISPR/Cas9 system using this PN
protocol, we chose the sgRNA/Cas9-STAT2-nd vector for the
test. In total, 215 embryos were injected and transferred into
recipients, leading to the birth of 28 golden hamster pups
(Table 3). We used black Syrian females mated with black Syrian
males the night before embryo transfer (ET) as recipients, because
it was reported that in vitro manipulated hamster embryos tend to
have low viability and are insufficient to signal implantation when
transferred to pseudopregnant females [27]. We used hair color to
distinguish pups produced from injected embryos from pups
produced from natural mating (the black hamster colony is true
breeding, i.e. never produced a golden pup without transferring
golden embryos into the females). Figure 2A shows a black
surrogate mother with her three golden and seven black pups that
were at two weeks of age. Genotyping analysis with the PCRRFLP assays (PCR primer sequences are listed in Table 4)
identified that four of the 28 golden pups carry targeted mutations
in the STAT2-nd locus. Figure 2B shows a representative PCRRFLP assay by which five golden pups were confirmed as wild
type (C1-C4 and C7) and two as genetically modified (C5 and C6).
Sanger sequencing analysis of the four targeted golden pups
revealed that animal A4 (female) and animal B8 (male) are
heterozygous for a nine-nucleotide deletion, animal C5 (male) is
genetically mosaic carrying eight-, nine- and 439-nucleotide
deletions and one-nucleotide insertion, and C6 (female) is
genetically mosaic for eight- and nine-nucleotide deletions and
one-nucleotide insertion (Figure 2C). To investigate if the mutations can be transmitted to the germline, we bred all four STAT2targeted hamsters with their wild type littermates. By using the
PCR-RFLP assay and Sanger sequencing, we demonstrated that
all of the mutations were transmitted to F1 offspring, with the
exception of the eight- and 439-nucleotide deletions from the
mosaic animals C6 and C5, respectively. Figure 2D shows the
genotyping results on the 12 littermates produced by mating the
C6 founder female with a wild type male littermate. We have yet
to confirm whether the eight- and 439-nucleotide deletions failed
to be transmitted to the germline at all or were transmitted with
low germline penetrance, since we have only produced the first
litters of pups from these two animals so far. We also bred some of
the heterozygous F1 littermates and have produced homozygous
F2 offspring carrying the nine-nucleotide deletion and the onenucleotide insertion, respectively (Figure 2E). Western blotting
using the tissue lysates from the F2 homozygous hamsters showed
that STAT2 protein expression was totally abolished in the onenucleotide insertion mutants, but not in the nine-nucleotide
deletion mutants (Figure 2F; results from the comparison between
one STAT2 KO and one nine-nucleotide deletion hamsters are

Development of a PN injection protocol in the Syrian
hamster
We then focused on developing a PN injection protocol in
hamsters for producing genetically targeted animals. In contrast to
the situation in other species such as the mouse and rat, Syrian
hamster embryos are extremely sensitive to in vitro handling. For
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Figure 1. Gene targeting in golden Syrian hamster somatic cells by CRISPR/Cas9. (A) Schematic diagram for the targeting sites at STAT2,
KCNQ1 and PPP1R12C loci by sgRNAs. The sgRNA target sequences for each locus are depicted, with the restriction enzyme recognition sites used for
the PCR-RFLP assays underlined. Letters in red are the protospacer adjacent motif (PAM) (3). Arrows: locations of PCR primers. (B) Gene targeting
efficiency at the STAT2-nd, STAT2-cc1, STAT2-cc2, KCNQ1, and PPP1R12C loci in BHK cells detected by PCR-RFLP assays. M: 1 kb Plus DNA Ladder; C:
controls (untransfected BHK cells); T: transfected BHK cells. (C) Indels introduced by CRISPR/Cas9 for the STAT2-nd, KCNQ1, and PPP1R12C loci in BHK
cells. Letters in blue are sgRNA target sequences (with PAM in red). Nucleotide deletions and insertions are indicated by dashes and orange letters,
respectively. (D) PCR-RFLP assays on single cell derived BHK cell colonies. WT: wild type; D1 nt, D2 nt, D3 nt, D4 nt, D5 nt, D8 nt, and D13 nt: one-,
two-, three-, four-, five-, eight-, and 13-nucleotide deletion, respectively; +1 nt and +2 nt: one- and two-nucleotide insertions, respectively; -/-: both
alleles targeted, and +/-: single allele targeted.
doi:10.1371/journal.pone.0109755.g001

Table 1. DNA oligos for sgRNA/Cas9 vector construction and in vitro transcription.

Name

Sequence

sgRNA-stat2-ndF

CACCGAATCAGGCTCAGAGATCTC

sgRNA-stat2-ndR

AAACGAGATCTCTGAGCCTGATTC

sgRNA-stat2-cc1F

CACCGATATGTCCAGAGCACAATT

sgRNA-stat2-cc1R

AAACAATTGTGCTCTGGACATATC

sgRNA-stat2-cc2F

CACCGCCTCTGTCTCGCAGGTTGA

sgRNA-stat2-cc2R

AAACTCAACCTGCGAGACAGAGGC

sgRNA-kcnq1F

CACCGGCTGCCGCAGCAAGTACGT

sgRNA-kcnq1R

AAACACGTACTTGCTGCGGCAGCC

sgRNA-ppp1r12cF

CACCGGAACCTGTGACCTCAGGCC

sgRNA- ppp1r12cR

AAACGGCCTGAGGTCACAGGTTCC

Cas9rF

TAATACGACTCACTATAGGGAGATCGCCACCATGGACTATAAGGACCACGAC

Cas9rR

GCGAGCTCTAGGAATTCTTAC

stat2-ndrF

TTAATACGACTCACTATAGGGAATCAGGCTCAGAGATCTC

stat2-ndrR

AAAAGCACCGACTCGGTGCC

doi:10.1371/journal.pone.0109755.t001
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Table 2. PN injection conditions in golden Syrian hamsters.

Conditions tested

Conditions identified

Comments

Timing of PN stage embryo collection

10 hours post–egg activation (PEA)

For highest number of PN embryo recovery and most
suitable for PN injection

Timing of PN injection

10.5 to 12.5 hours PEA

PN can be best visualized for localization at this time
window

Maximum time length embryos can
be left on injection stage

60 minutes

15 minutes injection time length is currently used

Maximum DNA injection volume

1–2 pl

.2 pl results in increased embryo lysis rate independent
of PN injection time

Maximum DNA concentration

10 ng/ml

.10 ng/ml results in increased embryo lysis rate
independent of PN injection time

Embryo handling conditions

Manipulation medium: Equilibrated HECM-9 medium

Equilibrated HECM-9 medium buffered with Hepes may
also be used

Ambient environment for embryo handling

The ambient temperature is 2860.5uC and embryos are
handled on a heated plate at 37.5uC

Hamster embryos are sensitive to temperature
fluctuations

doi:10.1371/journal.pone.0109755.t002

www.ncbi.nlm.nih.gov/genome/11998) with the targeting sequence by sgRNA/Cas9-STAT2-nd as the query to find the
genomic sequences with the highest homology, i.e., zero to two
nucleotide mismatches in the seed sequence [3]. In total, we chose
eight potential off-site targets (O1 to O8) which share the highest
sequence homology to the seed sequence of the target site
(Table 5) and subjected them to PCR-RFLP assays by using the
genomic DNA isolated from STAT2-targeted hamsters. Our
results showed that none of these sequences was targeted by the
sgRNA/Cas9-STAT2-nd vector (Figure 3), even though they
share high degrees of sequence homology with the targeting
sequence. This result indicates that the CRIPSR/Cas9 system is

shown). To our knowledge, this is the first successful gene targeting
in hamsters and production of live hamsters carrying targeted
mutations in their germline. Similar to what has been observed in
STAT2 KO mice [28], STAT2 targeted hamsters develop and
breed normally.

Analysis of off-site targeting in STAT2 KO hamsters
It was reported that CRISPR/Cas9 can introduce off-site
targeting [29]. To examine whether off-site targeting occurred in
the STAT2-targeted hamsters, we conducted blast search on the
golden Syrian hamster nucleotide sequence database (http://

Figure 2. Production of STAT2-targeted golden Syrian hamsters by PN injection of sgRNA/Cas9-STAT2-nd gene targeting vector. (A)
A litter of 2-week-old pups, three golden and seven black, along with the surrogate black mother. (B) Genotyping results by the PCR-RFLP assay on
seven golden pups produced by PN injections. Pups C1-C4 and C7 are wild type; pups C5 and C6 are genetically modified in the STAT2-nd locus. (C)
Indels introduced into the STAT2-nd locus of the four golden pups, A4, B8, C5 and C6. The frequencies of DNA subclones with each of the indels are
indicated by numbers following the indel signs. (D) Genotyping results with the PCR-RFLP assay on the 12 F1 pups produced by breeding founder
animal C6 with a wild type littermate. (E) Genotyping results with the PCR-RFLP assays on the seven F2 pups produced by crossing the two
littermates, #6 (male) and #8 (female), both of which are the offspring from founder animal C6. (F) Western blotting assay to compare the expression
of STAT2 protein in wild type, homozygous one-nucleotide insertion and nine-nucleotide deletion hamsters. Definitions for symbols are listed in
Figure 1 legend.
doi:10.1371/journal.pone.0109755.g002
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Figure 3. Detection of off-site targeting with PCR-RFLP assays in hamsters produced by DNA injection. Genomic DNA isolated from
toes clipped from the four targeted hamsters was used for detecting the off-site targeting with the PCR-RFLP assays. O1-O8: the eight potential offsite targets. Left panel shows PCR products before restriction enzyme digestion and the right panel shows PCR products after restriction enzyme
digestion (note the band size changes after restriction enzyme digestions). *: multiple PCR bands due to non-specific DNA amplification (the bottom
band is the correct PCR product).
doi:10.1371/journal.pone.0109755.g003

efficiency of coinjection of in vitro transcribed Cas9 mRNA and
sgRNA to produce genetically targeted hamsters. After optimizing
the conditions for cytoplasmic injection (detailed in Methods
section), we coinjected Cas9 mRNA and the sgRNA for STAT2nd into the cytoplasm of PN stage embryos, followed by
transferring the injected embryos to recipient females. Our results
showed that coinjection of Cas9 mRNA and sgRNA is highly

specific in introducing targeted mutations into the golden Syrian
hamster genome.

Production of STAT2 KO hamsters by cytoplasmic
injection of RNA
Following the success of producing genetically targeted hamsters
with this PN injection protocol, we evaluated the feasibility and

Table 3. Production of STAT2-targeted golden Syrian hamsters by PN and cytoplasmic injection.

Injection methods

# of transferred
embryos

Live Newborns
# of golden pups (% of
transferred embryos)

# of STAT2-modified pups
(% of total golden pups)

# of STAT2-modified pups (% of
transferred embryos)

PN injection (DNA)

215

28 (13.0)

4 (14.3)

4 (1.9)

Cytoplasmic injection (RNA)

229

54 (23.6)*

48 (88.9)**

48 (21.0)**

Note: The data were analyzed by Chi-square test.* p,0.01; ** p,0.001.
doi:10.1371/journal.pone.0109755.t003

PLOS ONE | www.plosone.org

5

October 2014 | Volume 9 | Issue 10 | e109755

Gene Targeting in Golden Syrian Hamsters

Table 4. PCR primers for PCR-RFLP assays.

Category
For designated targets

For potential off-site targets

Name

Sequence

Note

BglF

GTACAGGGAAGAGCTGGAACTGATG

For sgRNA/Cas9-STAT2-nd

BglR

CTGTATCCTCTGTGACACTTGCCAC

For sgRNA/Cas9-STAT2-nd
For sgRNA/Cas9-STAT2-cc1

BsiF

AGAGAAGAAGACACCATCTTTGGAC

BsiR

CTAGCCTCAACTGTCAGTTCTTGTG

For sgRNA/Cas9-STAT2-cc1

HincF

GCCCTGGGTTCTTCTTAGTCAAGTC

For sgRNA/Cas9-STAT2-cc2

HincR

GAGCAGGCGTTGTAGTAACTCTGTG

For sgRNA/Cas9-STAT2-cc2

BsaF

GAGATCGTCCTGGTGGTGTTCTTTG

For sgRNA/Cas9-KCNQ1

BsaR

GCAACTCTTGGTTCTGATGCGGGTC

For sgRNA/Cas9-KCNQ1

StuF

GTCTTTGACCAGTCCAGGAG

For sgRNA/Cas9-PPP1R12C

StuR

TGAATGTCCCTGCTTTCCTG

For sgRNA/Cas9-PPP1R12C

O1F

GCACACAGTACAGCAATGGTCG

O1R

GCTACACAGAGAAACCCTGACTGG

O2F

TTGTGTATAGTGGCAGGTTGGAG

O2R

CCGAGTCCAACCGAAACCTATC

O3F

CAATGTTCCCTGAGCCTTAAGTG

O3R

GTGTATGCATGTCCATGTGTGC

O4F

ATGTAACAACCAGGGGTGACTTC

O4R

GGCTTCCAACAACTCACACACAC

O5F

CTGAGGTAAGGTTTGTGATGTTG

O5R

CACACATACACGTCTTCTCCTG

O6F

CTCTTGTGGTCTTTGCCAGTTTG

O6R

AAGGTCCAAGGAGCCTTGGTGAG

O7F

CCAGTTGTTGTCATTTGTGAGAG

O7R

ACTCTCCACACCTGCTTCAACTG

O8F

GCTAAGAGAATGTGTAAACTCAC

O8R

TCTCCAGTCTAAATATCATAGTGG

doi:10.1371/journal.pone.0109755.t004

efficient in targeting the hamster genome, with 48 of the 54
(88.9%) golden hamsters produced being genetically modified
(Table 3). Figure 4 shows a representative genotyping result for
the produced animals with the PCR-RFLP assay. Compared to
injecting DNA vectors expressing sgRNA/Cas9, RNA injection is
significantly more efficient in introducing targeted mutations in the
hamster (p,0.001; Table 3). Among the targeted hamsters, five

were identified as biallelically targeted and the rest as heterozygously/mosaically targeted (carrying a wild type allele along
with one or more types of indels) in the STAT2 locus by Sanger
sequencing. We subjected five of the biallelically targeted and 20
randomly chosen heterozygously/mosaically targeted hamsters to
off-targeting analysis and found no off-targeting event (Figure 5).
Therefore, we demonstrated that coinjection of Cas9 mRNA and

Table 5. Top eight potential off-targets by sgRNA/Cas9-STAT2-nd.

Sites

Sequences*

Sequence ID and location of sites

Restriction enzymes

O1

ggtTCAGaCTCAGAGcTCTCAGG

Sequence ID: NW_004801690.1 Range 23: 4636728 to 4636747

SacI

O2

ggccCAGGCTCAGAGAcCTCAGG

Sequence ID: NW_004801690.1 Range 1: 4734434 to 4734452

Bsu36I

O3

catggAGGCTCAGAGATaTCAGG

Sequence ID: NW_004801622.1 Range 2: 11824588 to 11824605

EcoRV

O4

gtacagGGCTgAGAGATCTCAGG

Sequence ID: NW_004801633.1 Range 3: 3439805 to 3439821

BglII

O5

tttctgtGCTCAGAGATCTCAGG

Sequence ID: NW_004801707.1 Range 1: 1561837 to 1561852

BglII

O6

tcttgctGCTCAGAGATCTCAGG

Sequence ID: NW_004801815.1 Range 1: 759646 to 759661

BglII

O7

ctaggatcCTCAGAGATCTCAGG

Sequence ID: NW_004801691.1 Range 1: 1923240 to 1923254

BglII

O8

tgtcacttCTCAGAGATCTCAGG

Sequence ID: NW_004801670.1 Range 1: 5134136 to 5134150

BglII

*PAM is indicated in bold and italic letters. Nucleotide mismatches between the target sequence and the potential off-target sequences are in lower-case, with the ones
within the seed sequence italicized.
doi:10.1371/journal.pone.0109755.t005
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sgRNA is highly efficient and specific at targeting the hamster
genome, at a rate very similar to those observed in mice [11] or
rats [5]. Furthermore, we found that the percentage of transferred
embryos developing to live pups from RNA injection is
significantly higher than from DNA injection (Table 3; p,0.01).
It is likely that cytoplasmic injection is less detrimental than PN
injection.

homology with the targeting sequence in the STAT2 gene could
also have been targeted, our data are in agreement with the recent
findings revealed by high-coverage whole-genome sequencing (the
most thorough approach employed to date in analyzing offtargeting events) that the incidents of off-targeting by CRIPSR/
Cas9 is relatively low [35,36]. Nevertheless, we are planning to
conduct more extensive sequence analysis, such as with wholegenome sequencing, in the STAT2 KO and other genetically
engineered hamsters that are being created in our laboratory to
provide a thorough assessment on the off-targeting issue.
Considering the fact that the golden Syrian hamster has been
used to study several human diseases for which no other rodent
models are suitable [13–15], the work presented here should
complement other model organisms in the study of human disease.

Discussion
The production of genetically modified laboratory animals has
greatly advanced our understanding of gene function and disease
processes. Mice are by far the most commonly used mammalian
genetic models, largely due to the fact that embryonic stem (ES)
cells were first derived in mice and that homologous DNA
recombination-mediated gene targeting technology was first
established in mouse ES cells [30]. With the recent development
of engineered endonucleases, such as transcription activator-like
effector nucleases (TALENs) [31] and CRISPR/Cas9 [2,3], genes
have been targeted with high efficiency not only in mice but also in
several other model organisms previously considered to be
unamenable to gene targeting [8,9,32–34].
In this study, we first investigated whether the CRISPR/Cas9
system is efficient in introducing targeted mutations in Syrian
hamster genome. By constructing five different sgRNA/Cas9
expressing vectors designed to target distinct genomic loci, we
demonstrated that the CRISPR/Cas9 system is highly efficient in
introducing site-specific genetic mutations in the hamster genome
when transfected into BHK cells. We then developed PN and
cytoplasmic microinjection protocols for introducing the
CRISPR/Cas9 system into PN stage hamster embryos to produce
hamsters carrying targeted genetic modifications. We achieved this
by systematically testing the in vitro embryo handling conditions
that are permissive for hamster embryo development and by
optimizing the microinjection parameters. We further demonstrated that injection of the CRISPR/Cas9 system into PN stage
embryos is highly efficient at producing germline-transmitted sitespecific genetic modifications in hamsters. Our work also led to the
production of hamsters carrying germline-transmitted targeted
mutations in both of the STAT2 alleles. We also further
demonstrated that, by examining each of the hamster genomic
loci that shares the highest sequence homology with the targeting
sequence in the STAT2 gene, the CRISPR/Cas9 system is highly
specific and did not generate any off-targeting event in these
examined loci of the produced hamsters. Even though we
currently cannot totally rule out the possibility that other yet to
be characterized sequences in the hamster genome sharing high

Materials and Methods
Gene targeting in BHK cells
The sgRNA/Cas9 gene targeting vectors were constructed by
using the pX330-U6-Chimeric_BB-CBh-hSpCas9 plasmid (Addgene ID: 42230) as described by Cong L et al. [2]. The sgRNA/
Cas9 targeting sites for each of the genomic loci of interest were
identified by searching for the G(N)20GG motifs. The corresponding DNA oligos (listed in Table 1) for each of the targeting sites
were synthesized by Integrated DNA Technologies (Iowa, USA).
The final constructs were confirmed by Sanger sequencing. Baby
hamster kidney fibroblasts (BHK; ATCC) were cultured in
Minimum Essential Medium (MEM) supplemented with 10%
fetal bovine serum (FBS), non-essential amino acids, and
Penicillin-Streptomycin (Life Technologies). Five mg of circular
sgRNA/Cas9 vectors were transfected into 106 BHK cells using
Amaxa 4D-Nucleofector (Program No. CA-137; Lonza). Two
days post transfection, cells were harvested for genomic DNA
isolation by using Puregene Core Kit A (Qiagen) following the
manufacturer’s protocol. Each of the target genomic loci was PCR
amplified from the genomic DNA isolated from BHK cells or
hamster biopsies by Phusion High-fidelity DNA polymerase
(Thermo Scientific) with the PCR primers listed in Table 4. After
digestion with the chosen enzyme, the PCR products were
resolved on a 1% agarose gel and stained with SYBR green dye
(Life Technologies). Based on whether the PCR products were
fully or partially resistant to digestion by a chosen restriction
enzyme (indels introduced by sgRNA/Cas9 vectors would abolish
the restriction recognition site), indels were detected. To determine
gene targeting efficiency by each of the sgRNA/Cas9 vectors, the
relative intensities of uncut band and cut bands were analyzed by
using the Image J software (1.47p, NIH).

Animals
Golden Syrian hamsters used for PN embryo production were
bred in-house by using founder animals purchased from Charles
River (LVG Golden Syrian Hamster, Strain Code: 049). Black
Syrian hamsters used as recipients for embryo transfer were from a
breeding colony established in our laboratory. All hamsters were
raised and maintained in an air-conditioned room with a 14L:10D
light cycle (light from 0600).

Ethics Statement

Figure 4. Genotyping with PCR-RFLP assays of STAT2-targeted
golden Syrian hamsters produced by cytoplasmic injection of
Cas9 mRNA and sgRNA. Typical genotyping results by the PCR-RFLP
assay from seven animals are shown. M: 1 kb Plus DNA Ladder; 1–4:
heterozygously or mosaically targeted; 5–6: biallelically targeted; 7: wild
type.
doi:10.1371/journal.pone.0109755.g004
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The experiments were conducted in strict accordance with
guidelines of the AAALAC-accredited Laboratory Animal Research Center at the Utah State University and approved by the
Institutional Animal Care and Use Committee of Utah State
University (IACUC Protocol: 2091). All surgery was performed
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Figure 5. Detection of off-site targeting with the PCR-RFLP assays in hamsters produced by RNA injection. Assay results for five of the
25 analyzed animals are shown. G#: IDs for the analyzed animals. Definitions for symbols and other information are provided in the legend of
Figure 3.
doi:10.1371/journal.pone.0109755.g005

mineral oil was used as injection medium. A group of 7–10
embryos were transferred to a 50 ml HECM-9 drop on the
microinjection dish and 1–2 pl of DNA solution was injected into
the pronucleus of an embryo; the injection for each group of
embryos was finished within 15 min. Microinjections were
performed on a heated microinjection stage (37.5uC) with red
filters and all the embryo handling procedures were performed in
a dark room with a small incandescent lamp (13 W and 120 V).
After injection, embryos were washed twice with equilibrated
HECM-9 and cultured in HECM-9 covered by mineral oil for at
least 0.5 h before embryo transfer. For PN injection, the injection
solution was supercoiled DNA purified by using the QIAquick Gel
Extraction Kit (Qiagen) and diluted to 2 ng/ml with TE buffer
(10 mM Tris-HCl/0.1 mM EDTA, pH 7.5). For cytoplasmic
injection, the injection solution was in vitro transcribed Cas9
mRNA (100 ng/ml) and sgRNA (50 ng/ml) dissolved in TE buffer
and mixed at 1:1 volume ratio. About 5–10 pl RNA solution was
injected into the cytoplasm of an embryo. Injected embryos with
normal morphology were transferred to each oviduct (10–20
embryos per oviduct) of recipient black Syrian females which were
naturally mated with black males 1 day previously. Recipients
were allowed to naturally deliver and raise their pups.

under by Ketamine/Xylazine anesthesia, and all efforts were
made to minimize suffering.

Embryo Manipulations
Eight to 12 week old female golden Syrian hamsters were
induced to superovulate by an i.p. injection of 10-20 IU (indexed
to body weight as described by McKiernan and Bavister) [37] of
PMSG (Sigma-Aldrich) at 9:00 AM on the day of post-estrus
discharge (Day 1 of estrous cycle). Females were mated to fertile
males at 7:00 PM on Day 4 of the estrous cycle. PN embryos were
collected from oviducts approximately 19 h after mating. Embryos
were flushed from oviducts with warmed and equilibrated HECM9 medium supplemented with 0.5 mg/ml human serum albumin
(Sigma-Aldrich). All embryos were then washed twice, transferred
into 20 ml drops of HECM-9 covered by mineral oil (SigmaAldrich) in groups of 7-10 in a culture dish and cultured at 37.5uC
under 10% CO2, 5% O2, and 85% N2. Culture dishes were preequilibrated for at least 5 h before use. The experiments were
performed in a dark room with a small incandescent lamp, and red
filters were used on the microscope light source, as described by
Takenaka et al. [25].
The microinjection station set up for PN injections in the
hamster is the same as the one developed for the mouse [38], but
with embryo manipulation conditions uniquely developed for the
hamster (for details see Table 1). In brief, fully equilibrated
HECM-9 (37.5uC, 10% CO2, 5% O2, and 85% N2) covered by
PLOS ONE | www.plosone.org

Western blotting
Ear biopsies were collected from the wild type, homozygous
one-nucleotide insertion and nine-nucleotide deletion mutants.
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Tissues were grinded in liquid nitrogen and then lysed in lysis
buffer (150 mM NaCl, 1.0% Triton X-100 and 50 mM Tris,
pH 8.0, with protease inhibitor cocktails (Sigma)). Gross protein
mass was quantified by Pierce BCA protein assay kit (Thermo
Scientific) according to the manufacturer’s protocol. Tissue lysates
were separated on NuPAGE 4–12% Bis-Tris gel (Life Technologies) and then electrotransferred to PVDF membrane (Life
Technologies). The blocking and washing steps were performed
using the WesternBreeze chemiluminescent kit (Life Technologies)
and strictly followed the manufacturer’s protocol. The membrane
was incubated with the primary antibody rabbit polyclonal antiSTAT2 antibody (sc-839, Santa Cruz) or mouse polyclonal anti-bactin antibody (sc-47778, Santa Cruz) for 1 h. After washing, the
membrane was incubated with the alkaline phosphatase conjugated secondary antibody (anti-rabbit or anti-mouse) for 30 min
and was exposed to X-ray film for 1–5 min.
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